The exclusion of people with psychiatric disorders from medical research

被引:44
作者
Humphreys, Keith [1 ,2 ]
Blodgett, Janet C. [2 ]
Roberts, Laura Weiss [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA
[2] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Menlo Pk, CA 94025 USA
关键词
Randomized trials; Psychiatric exclusion criteria; External validity; Systematic review; Ethics; Generalizability; ELIGIBILITY CRITERIA; CLINICAL-TRIALS;
D O I
10.1016/j.jpsychires.2015.08.005
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
People with psychiatric disorders are excluded from medical research to an unknown degree with unknown effects. We examined the prevalence of reported psychiatric exclusion criteria using a sample of 400 highly-cited randomized trials (2002-2010) across 20 common chronic disorders (6 psychiatric and 14 other medical disorders). Two coders rated the presence of psychiatric exclusion criteria for each trial. Half of all trials (and 84% of psychiatric disorder treatment trials) reported possible or definite psychiatric exclusion criteria, with significant variation across disorders (p < .001). Non-psychiatric conditions with high rates of reported psychiatric exclusion criteria included low back pain (75%), osteoarthritis (57%), COPD (55%), and diabetes (55%). The most commonly reported type of psychiatric exclusion criteria were those related to substance use disorders (reported in 48% of trials reporting at least one psychiatric exclusion criteria). General psychiatric exclusions (e.g., "any serious psychiatric disorder") were also prevalent (38% of trials). Psychiatric disorder trials were more likely than other medical disorder trials to report each specific type of psychiatric exclusion (p's < .001). Because published clinical trial reports do not always fully describe exclusion criteria, this study's estimates of the prevalence of psychiatric exclusion criteria are conservative. Clinical trials greatly influence state-of-the-art medical care, yet individuals with psychiatric disorders are often actively excluded from these trials. This pattern of exclusion represents an under-recognized and worrisome cause of health inequity. Further attention should be paid to how individuals with psychiatric disorders can be safely included in medical research to address this important clinical and social justice issue. Published by Elsevier Ltd.
引用
收藏
页码:28 / 32
页数:5
相关论文
共 21 条
  • [1] [Anonymous], 1990, Design sensitivity: Statistical power for experimental research
  • [2] [Anonymous], 2012, PUBLIC MENTAL HLTH
  • [3] Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
    De Hert, Marc
    Correll, Christoph U.
    Bobes, Julio
    Cetkovich-Bakmas, Marcelo
    Cohen, Dan
    Asai, Itsuo
    Detraux, Johan
    Gautam, Shiv
    Moeller, Hans-Jurgen
    Ndetei, David M.
    Newcomer, John W.
    Uwakwe, Richard
    Leucht, Stefan
    [J]. WORLD PSYCHIATRY, 2011, 10 (01) : 52 - 77
  • [4] Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Gandhi, M
    Ameli, N
    Bacchetti, P
    Sharp, GB
    French, AL
    Young, M
    Gange, SJ
    Anastos, K
    Holman, S
    Levine, A
    Greenblatt, RM
    [J]. AIDS, 2005, 19 (16) : 1885 - 1896
  • [5] THE MACARTHUR TREATMENT COMPETENCE STUDY .3. MEASURES OF PATIENTS TO CONSENT TO PSYCHIATRIC AND MEDICAL TREATMENTS
    GRISSO, T
    APPELBAUM, PS
    [J]. LAW AND HUMAN BEHAVIOR, 1995, 19 (02) : 149 - 174
  • [6] Reporting the recruitment process in clinical trials: Who are these patients and how did they get there?
    Gross, CP
    Mallory, R
    Heiat, A
    Krumholz, HM
    [J]. ANNALS OF INTERNAL MEDICINE, 2002, 137 (01) : 10 - 16
  • [7] Are Participants in Pharmacological and Psychotherapy Treatment Trials for Social Anxiety Disorder Representative of Patients in Real-Life Settings?
    Hoertel, Nicolas
    de Maricourt, Pierre
    Katz, Julien
    Doukhan, Raphael
    Lavaud, Pierre
    Peyre, Hugo
    Limosin, Frederic
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (06) : 697 - 703
  • [8] Holt JB, 2015, MMWR RECOMM REP, V64, P1
  • [9] Prevalence and predictors of research participant eligibility criteria in alcohol treatment outcome studies, 1970-98
    Humphreys, K
    Weingardt, KR
    Horst, D
    Joshi, AA
    Finney, JW
    [J]. ADDICTION, 2005, 100 (09) : 1249 - 1257
  • [10] Subject eligibility criteria can substantially influence the results of alcohol-treatment outcome research
    Humphreys, Keith
    Harris, Alex H. S.
    Weingardt, Kenneth R.
    [J]. JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2008, 69 (05) : 757 - 764